ZimVie (NASDAQ:ZIMV) Announces Quarterly Earnings Results

ZimVie (NASDAQ:ZIMVGet Free Report) issued its quarterly earnings data on Wednesday. The company reported $0.27 earnings per share for the quarter, topping analysts’ consensus estimates of $0.25 by $0.02, Zacks reports. The firm had revenue of $111.52 million for the quarter, compared to analyst estimates of $113.67 million. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. ZimVie updated its FY 2025 guidance to 0.800-0.950 EPS.

ZimVie Stock Down 1.7 %

ZIMV stock opened at $12.88 on Friday. ZimVie has a fifty-two week low of $12.25 and a fifty-two week high of $22.40. The company has a market capitalization of $355.48 million, a price-to-earnings ratio of -0.98 and a beta of 2.10. The business’s 50 day moving average price is $13.75 and its two-hundred day moving average price is $14.78. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.38 and a current ratio of 1.94.

Analysts Set New Price Targets

Separately, Needham & Company LLC reissued a “buy” rating and set a $23.00 price objective on shares of ZimVie in a research report on Thursday.

Read Our Latest Report on ZimVie

About ZimVie

(Get Free Report)

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.

Featured Articles

Earnings History for ZimVie (NASDAQ:ZIMV)

Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.